{
    "title": "Roche ekes out full-year profit gain on Hemlibra, Tecentriq growth",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10471351/Roche-ekes-year-profit-gain-Hemlibra-Tecentriq-growth.html",
    "date": "2022-02-03",
    "keywords": [
        "cancer",
        "frankfurt",
        "drugmaker",
        "roche",
        "edge",
        "hemlibra",
        "haemophilia",
        "immunotherapy",
        "tecentriq",
        "decline",
        "operating",
        "profit",
        "interest",
        "tax",
        "oneoff",
        "statement",
        "thursday",
        "line",
        "estimate",
        "analyst",
        "poll",
        "core",
        "share",
        "percentage",
        "range",
        "exchange",
        "year",
        "effect",
        "repurchase",
        "novartis",
        "reporting",
        "burger",
        "michael"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}